Lokesh Guglani1, Shabaana A Khader. 1. Division of Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Abstract
PURPOSE OF REVIEW: Compelling evidence suggests that the Th17 lineage and other IL-17-producing cells play critical roles in host defense against pathogens at mucosal sites. However, IL-17 can also contribute to inflammatory responses at mucosal sites. In this review, we will discuss the recent progress in our understanding of the role of Th17 and other IL-17-producing cells in defining the fine balance between immunity and inflammation at different mucosal sites. RECENT FNDINGS: Recent findings have highlighted that Th17 cytokines are important for the induction of innate and adaptive host responses and contribute to host defense against pathogens at mucosal sites. More recent developments have probed how the Th17 responses are generated in vivo in response to infections and their requirement in maintaining barrier function at mucosal sites. Most importantly, it is becoming apparent that there is a fine balance between protective and pathological manifestation of Th17 responses at mucosal sites that defines immunity or inflammation. SUMMARY: In this review, we have summarized the recent advances in our understanding of Th17 cytokines and how they contribute to immunity versus inflammation at mucosal sites.
PURPOSE OF REVIEW: Compelling evidence suggests that the Th17 lineage and other IL-17-producing cells play critical roles in host defense against pathogens at mucosal sites. However, IL-17 can also contribute to inflammatory responses at mucosal sites. In this review, we will discuss the recent progress in our understanding of the role of Th17 and other IL-17-producing cells in defining the fine balance between immunity and inflammation at different mucosal sites. RECENT FNDINGS: Recent findings have highlighted that Th17 cytokines are important for the induction of innate and adaptive host responses and contribute to host defense against pathogens at mucosal sites. More recent developments have probed how the Th17 responses are generated in vivo in response to infections and their requirement in maintaining barrier function at mucosal sites. Most importantly, it is becoming apparent that there is a fine balance between protective and pathological manifestation of Th17 responses at mucosal sites that defines immunity or inflammation. SUMMARY: In this review, we have summarized the recent advances in our understanding of Th17 cytokines and how they contribute to immunity versus inflammation at mucosal sites.
Authors: Christopher R Crowe; Kong Chen; Derek A Pociask; John F Alcorn; Cameron Krivich; Richard I Enelow; Ted M Ross; Joseph L Witztum; Jay K Kolls Journal: J Immunol Date: 2009-09-25 Impact factor: 5.422
Authors: Sumathi Sankaran; Michael D George; Elizabeth Reay; Moraima Guadalupe; Jason Flamm; Thomas Prindiville; Satya Dandekar Journal: J Virol Date: 2007-10-24 Impact factor: 5.103
Authors: K Kai McKinstry; Tara M Strutt; Amanda Buck; Jonathan D Curtis; John P Dibble; Gail Huston; Michael Tighe; Hiromasa Hamada; Stewart Sell; Richard W Dutton; Susan L Swain Journal: J Immunol Date: 2009-06-15 Impact factor: 5.422
Authors: Justin H Fransen; Luuk B Hilbrands; Jurjen Ruben; Monique Stoffels; Gosse J Adema; Johan van der Vlag; Jo H Berden Journal: Arthritis Rheum Date: 2009-08
Authors: Yinyao Lin; Shane Ritchea; Alison Logar; Samantha Slight; Michelle Messmer; Javier Rangel-Moreno; Lokesh Guglani; John F Alcorn; Heather Strawbridge; Sang Mi Park; Reiko Onishi; Nikki Nyugen; Michael J Walter; Derek Pociask; Troy D Randall; Sarah L Gaffen; Yoichiro Iwakura; Jay K Kolls; Shabaana A Khader Journal: Immunity Date: 2009-10-22 Impact factor: 31.745
Authors: Puja Bagri; Varun C Anipindi; Philip V Nguyen; Danielle Vitali; Martin R Stämpfli; Charu Kaushic Journal: J Virol Date: 2017-11-14 Impact factor: 5.103
Authors: Tatiana M Clemente; Minal Mulye; Anna V Justis; Srinivas Nallandhighal; Tuan M Tran; Stacey D Gilk Journal: Infect Immun Date: 2018-09-21 Impact factor: 3.441
Authors: Luca Micci; Barbara Cervasi; Zachary S Ende; Robin I Iriele; Elane Reyes-Aviles; Carol Vinton; James Else; Guido Silvestri; Aftab A Ansari; Francois Villinger; Savita Pahwa; Jacob D Estes; Jason M Brenchley; Mirko Paiardini Journal: Blood Date: 2012-09-18 Impact factor: 22.113
Authors: Daniel T Claiborne; Timothy E Dudek; Colby R Maldini; Karen A Power; Musie Ghebremichael; Edward Seung; Elizabeth F Mellors; Vladimir D Vrbanac; Katharine Krupp; Abigail Bisesi; Andrew M Tager; David M Knipe; Christian L Boutwell; Todd M Allen Journal: J Virol Date: 2019-09-30 Impact factor: 5.103
Authors: Michael A Collier; Robert D Junkins; Matthew D Gallovic; Brandon M Johnson; Monica M Johnson; Andrew N Macintyre; Gregory D Sempowski; Eric M Bachelder; Jenny P-Y Ting; Kristy M Ainslie Journal: Mol Pharm Date: 2018-10-15 Impact factor: 4.939
Authors: Tiffany Hensley-McBain; Alexander S Zevin; Jennifer Manuzak; Elise Smith; Jillian Gile; Charlene Miller; Brian Agricola; Michael Katze; R Keith Reeves; Colleen S Kraft; Stanley Langevin; Nichole R Klatt Journal: J Virol Date: 2016-04-29 Impact factor: 5.103